MyVU Latest Headlines
-
Flex Meal Deal returns for faculty, staff, and graduate and professional students
Flex Meals can be purchased in blocks of 10 meals and are regularly $150 (plus tax) per block. During the spring 2024 Flex Meal Deal, faculty, staff, and graduate and professional students will receive three bonus meals at no additional charge. This promotion begins Wednesday, Jan. 3, and runs through Wednesday, Jan. 10. Read MoreJan 2, 2024
-
Vanderbilt named spoke in ARPA-H Customer Experience Hub to better meet patient needs
Vanderbilt University expands its health care innovation role by joining the ARPA-H Customer Experience Hub as a spoke, aiming to advance patient-centric health care solutions. This is the second spoke designation with ARPA-H, underscoring Vanderbilt’s commitment to transformative health care research and accessibility for all Americans. Read MoreDec 21, 2023
-
Undergraduates: Take the annual Quality of Life Survey, help shape the student experience
Student Affairs and the Office of Undergraduate Education invite all undergraduate students to participate in Vanderbilt’s annual winter break Quality of Life Survey. The survey’s purpose is to better understand the nature of the undergraduate experience at Vanderbilt and the feedback we get from the QLS plays a big part in shaping university practices and resources. Please consider taking the survey to ensure that your experience is represented. Read MoreDec 13, 2023
-
REMINDER: Vanderbilt staff, faculty holiday discounts and giveaways available Dec. 15–18
Vanderbilt University is hosting several giveaways and discounts to show our appreciation for our staff and faculty’s hard work this year. Here is a reminder of what’s coming up. Read MoreDec 13, 2023
-
Refugee journeys illuminated: A look at Vanderbilt’s partnership with nonprofit NICE
Vanderbilt recently supported the Nashville International Center for Empowerment’s "Nicest Night in Nashville," an event celebrating immigrant and refugee communities while raising funds for housing, employment, education and other resources for newly arrived individuals and families. Read MoreDec 13, 2023
-
Kit Neikirk named Marshall Scholar; will study at University of Edinburgh and University College London
As a Marshall Scholar, considered among the most accomplished undergraduates and recent graduates in the U.S., Neikirk will pursue advanced degrees in social determinants of health and biomedical imaging. Read MoreDec 12, 2023
-
Daniel Fleetwood named distinguished National Academy of Inventors Fellow
Daniel M. Fleetwood, Olin H. Landreth Professor of Engineering, has been named a National Academy of Inventors Fellow, the highest professional distinction awarded solely to academic inventors. Fleetwood, who is a professor of electrical engineering as well as physics, is best known for his research into radiation effects on microelectronic devices and materials, low-frequency noise,... Read MoreDec 12, 2023
-
Fall Undergraduate Research Fair showcases record-breaking number of presenters
The fall Vanderbilt Undergraduate Research Fair welcomed more than 500 guests and featured 212 undergraduate presenters in a variety of disciplines. The Nov. 9 event boasted the largest number of student presenters in the fall program’s history. Read MoreDec 11, 2023
-
Reevaluate your commute needs with updated parking calculator; apply for daily parking by Dec. 19 for January garage access
Commuting needs change over time. MoveVU’s commute calculator, with the added feature of specifying number of weeks on campus, can help determine which parking option may be best for you. Considering how many weeks per year you are on campus (and excluding time off for vacations, winter break, etc.) may alter your calculations. Read MoreDec 7, 2023
-
Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial
In just over two years, a Vanderbilt-Neumora collaboration has led to the Phase 1 clinical trial of a treatment for schizophrenia spectrum disorders, which affect 3.7 million adults in the United States. This is the third chemical compound discovered at the Warren Center for Neuroscience Drug Discovery to reach Phase 1 clinical trials. Read MoreDec 4, 2023